Even modest weight reduction can restore cycles in women who previously experienced oligomenorrhea or amenorrhea due to PCOS
Yet most primary care physicians (PCPs) are skeptical of telehealth platforms prescribing GLP-1s for weight loss
This unique receptor activity makes tirzepatide a promising candidate for improving bone health in obesity and diabetes, through the positive effects of GIP, and potentially GLP-1, on bone metabolism
Wellstar East Cobb Health Park
Whether you're a formulator seeking cutting-edge ingredients, a health practitioner looking for evidence-based solutions, or someone wanting to optimize your wellness, this guide will equip you with everything you need to know about butyrate and the innovative solutions now available
The pursuit of health is never entirely innocent. Ivan Illich A Timeline of Trials It began quietly in 2005 with exenatidethe first GLP-1 receptor agonist